Hipercolesterolemia familiar heterozigótica
Status:
Pausado
Sobre o estudo
Hipercolesterolemia familiar heterozigótica (fase 3)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Ldl-C Lowering Effect Of Bempedoic Acid With And Without Ezetimibe In Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Público alvo:
Pacientes pediátricos com hipercolesterolemia familiar heterozigótica
Centros ativos
Nenhum centro está recrutando no momento.